Procurement Summary
Country : USA
Summary : BioAnalytical Instruments Reagents and Supplies
Deadline : 13 May 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 118953170
Document Ref. No. : 75D301-25-Q-78604
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
This procurement is for the purchase of approved FDA reagents. FDA approved tests performed at the laboratory requre the use of the specific enzymes listed below:
SuperScript TM III Platinum TM CDC Triplex RT-PCR IDV EUA
SuperScript TM III Platinum TM CDC DENV-1-4 RT-PCR IDV 510K
TaPath TM CDC COVID-19 RT-PCR IDV 510K
TaPath TM CDC Influenza RT PCR IDV 510K
Active Contract Opportunity
Notice ID : 75D301-25-Q-78604
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : CENTERS FOR DISEASE CONTROL AND PREVENTION
Office: CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
Updated Published Date: May 09, 2025 09:34 am EDT
Original Published Date: May 09, 2025 09:05 am EDT
Updated Date Offers Due: May 13, 2025 04:00 pm EDT
Original Date Offers Due: May 13, 2025 04:00 pm EDT
Inactive Policy: Manual
Updated Inactive Date: May 13, 2025
Original Inactive Date: May 13, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 621511 - Medical Laboratories
Place of Performance: San Juan, PR 00920 USA
Documents
Tender Notice
SSJ_Redacted-MLG.pdf
Combined-Synopsis-Solicitation.pdf